|
CAL-101 (Idelalisib, GS-1101) is a selective p110delta inhibitor with IC50 of 2.5 nM, shown to have 40- to 300-fold greater selectivity for p110delta thanp110alpha/beta/gamma, and 400- to 4000-fold more selectivity to p110delta than C2beta, hVPS34, DNA-PK and mTOR. Phase 3. (CAS nr: 870281-82-6). Other sizes are often available. Please inquire.
|